Used as main image by Phynd in search results and profile page

Ronald K Potkul, MD

Gynecologic Oncology, Obstetrics & Gynecology

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

888-584-7888
Appointments (New Patients Welcome)
Provider Groups
  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
888-584-7888

Services & Specialties

Areas of Specialization

  • Gynecologic Oncology
  • Obstetrics & Gynecology

Clinical Interests

Conditions Treated

  • sentinel lymph node biopsy
  • cervical and endometrial cancer surgery
  • cervical and endometrial cancers
  • Complex Pelvic Surgery
  • Vaginal Cancer
  • gestational trophoblastic disease
  • minimally invasive gynecologic surgery
  • ovarian cancer
  • ovarian cancer surgery
  • Robotic Gynecological Surgery
  • gynecologic cancer surgery
  • vulvar cancer
  • leiomyosarcoma
  • paget's disease of vulva
  • radical vulvectomy
Show more

Locations & Contact

Primary Location

Loyola University Medical Center

2160 S First Ave
Maywood , IL 60153

View hours
Tuesday
8:00am - 5:00pm
Monday
8:00am - 5:00pm
Wednesday
8:00am - 5:00pm
Thursday
8:00am - 5:00pm
Friday
8:00am - 5:00pm
Saturday
8:00am - 5:00pm
Sunday
8:00am - 5:00pm
Loyola University Medical Center

About

Academic Title

Professor

Leadership Title

Department Chairperson, Obstetrics and Gynecology

Ages Seen

Adults - Over 65
Adults - 18 to 64

Additional Resources

Education & Certifications

Education

Education:
University of Chicago Pritzker School of Medicine (1981)

Internship:
University of Chicago Medical Center (1982)

Residency:
University of Chicago Medical Center (1985)

Fellowship:
Georgetown University Hospital (1988)

Board Certifications

Gynecologic Oncology, Gynecologic Oncology, American Board of Obstetrics & Gynecology Subspecialty (1990)

Gynecologic Oncology, Gynecologic Oncology, American Board of Obstetrics and Gynecology Subspecialty (1990)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Provider Ratings

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn More >

4.8 out of 5

(198 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

39 Reviews

09/10/2024

He is outstanding. I'm fortunate to be under hos care.

09/03/2024

thank you to Dr. Potkul. He has removed my cancer and my treatments are working to keep the cancer away

08/30/2024

God bless Dr Potkul and staff

08/30/2024

As I mentioned in previous feedback entry, Dr Potkul is wonderful, personable, and superb. Helps makes my situation, hopeful.

08/16/2024

Continuar con la misma calidad de servicio gracias

07/30/2024

He will answer any questions you have and he is very caring.

07/30/2024

Very good care

07/30/2024

I have been seeing him for many years now with treatments for cancer.

06/28/2024

Highly regarded

06/25/2024

He鈥檚 the best

06/21/2024

helping me navigate with diagnosis I am dealing with

06/18/2024

Dr. Potkul and his staff are excellent

06/18/2024

Been seeing Dr. Potkul for 9 years, the nest.

06/14/2024

Dr. Potkul is always nice.

06/07/2024

Explained exam and situation.

06/04/2024

He's fantastic

06/04/2024

The actual best reference is that I completely trust him.

05/24/2024

I have known Dr. Potkul for 8 years he is my guardian angel a superb human being.

05/03/2024

Very happy I switched over

04/30/2024

Dr. Potkul is a good doctor the only thing I would change is giving more information about what is going on or what a test is for.

04/26/2024

Been having some other concerns and didn鈥檛 review them

04/02/2024

Excellent

03/19/2024

I鈥檝e been seeing Dr Potkul since 2007. I am so thankful I found him.

03/19/2024

Thank you to all at the Bernadin Center.

03/12/2024

Great doctor, explains thing very well and has a good personality.

03/12/2024

Quick and easy -the therapy dogs were also sweet

03/12/2024

Dr. Potkul is always very caring and kind.

03/08/2024

Always make me feel comfortable and address any questions/issues I have. Thank you.

02/23/2024

Very sweet

02/20/2024

Dr. Potkul is one of the best doctors at Loyola

02/16/2024

Gentle and calm demeanor.

02/09/2024

Always feel taken care of by DrPotkul

02/09/2024

ITS ALWAYS BEEN A GOOD EXPERIENCE WITH DR. POTKUL. HE MAKES ME FEEL AT EASE.

02/06/2024

Very comfortable and nice.

01/30/2024

Just like I said before I feel comfy with Dr Potkul

01/30/2024

Overall made me feel very comfortable and confident I couldn鈥檛 have gone through this journey without Dr. Potkul and his staff.

01/26/2024

Dr.Potkul is excellent both professionally and his personality!

01/23/2024

I was very satisfied with eveyones performance. They all are very quick in everyone of my needs and concerns

01/23/2024

Quick to get appt and schedule surgery
Show more

Publications

  • Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer. Ross, D. H.; Gomez, K.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Goldberg, A.; Liotta, M.; Potkul, R.; Winder, A.; Lee, B.; Jackson, J.; Roeske, J. C.; Small, W.; Harkenrider, M. M.; Gynecologic oncology
  • Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice. Stiff, P. J.; Mehrotra, S.; Potkul, R. K.; Banerjee, S.; Walker, C.; Drakes, M. L.; Cancers
  • Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer. Buehner, T. M.; Liotta, M.; Potkul, R. K.; Wagner, R. H.; Savir-Baruch, B.; Molecular imaging and biology
  • Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management. Small, W.; Kim, Y. S.; Joyce, C.; Surucu, M.; Leshyk, M.; Harkenrider, M. M.; Potkul, R. K.; Liotta, M.; Winder, A.; Altoos, B.; Brachytherapy
  • Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers. Fukushiro-Lopes, D.; Hegel, A. D.; Russo, A.; Senyuk, V.; Liotta, M.; Beeson, G. C.; Beeson, C. C.; Burdette, J.; Potkul, R. K.; Gentile, S.; Frontiers in pharmacology
  • Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity. McAlarnen, L. A.; Ryan, K.; Adams, W.; Gliniewicz, A.; Winder, A. D.; Liotta, M. R.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Gynecologic oncology reports
  • Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients? Nieto, K.; Martin, B.; Pham, N.; Palmere, L.; Silva, S. R.; Winder, A.; Liotta, M.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Brachytherapy
  • Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer. Drakes, M. L.; Mehrotra, S.; Aldulescu, M.; Potkul, R. K.; Liu, Y.; Grisoli, A.; Joyce, C.; O'Brien, T. E.; Stack, M. S.; Stiff, P. J.; Journal of ovarian research
  • Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer. Kharouta, M. Z.; Pham, N.; Nieto, K.; Surucu, M.; Mysz, M. L.; Albuquerque, K.; Winder, A.; Liotta, M.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Brachytherapy
  • Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program. Harkenrider, M. M.; Surucu, M.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Yacoub, J.; Goldberg, A.; Liotta, M.; Winder, A.; Potkul, R.; Roeske, J. C.; Small, W.; Brachytherapy
  • Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. Potkul, R. K.; Unger, J. M.; Livingston, R. B.; Crew, K. D.; Wilczynski, S. P.; Salomon, C. G.; Smith, B. L.; Wong, L.; Campbell, D. L.; Einspahr, D. E.; Anderson, G. L.; Hershman, D.; Goodman, G. E.; Brown, P. H.; Meyskens, F. L.; Albain, K. S.; NPJ breast cancer
  • How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer. Harkenrider, M. M.; Shea, S. M.; Wood, A. M.; Chinsky, B.; Bajaj, A.; Mysz, M.; Yacoub, J. H.; Goldberg, A.; Liotta, M.; Potkul, R.; Surucu, M.; Roeske, J.; Small, W.; Journal of contemporary brachytherapy
  • Fatal case of luteinized thecoma with sclerosing peritonitis in a 40-year-old woman. Bahar, B.; Hu, Z.; Szpaderska, A.; Liotta, M.; Potkul, R. K.; Smith, D.; Erşahin, Ç.; International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Albuquerque, K.; Giangreco, D.; Morrison, C.; Siddiqui, M.; Sinacore, J.; Potkul, R.; Roeske, J.; International journal of radiation oncology, biology, physics
  • Hepatic resection for recurrent metastatic ovarian cancer. Abood, G.; Bowen, M.; Potkul, R.; Aranha, G.; Shoup, M.; American journal of surgery
  • FNA diagnosis of retroperitoneal leiomyosarcoma metastasizing to the breast. Omeroglu, G.; Ersşahin, C.; Potkul, R. K.; Booth, C. N.; Diagnostic cytopathology
  • Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid leukemia. Erşahin, C.; Omeroglu, G.; Potkul, R. K.; Salhadar, A.; Gynecologic oncology
  • Mesonephric adenocarcinoma of the vagina with a 3-year follow-up. Erşahin, C.; Huang, M.; Potkul, R. K.; Hammadeh, R.; Salhadar, A.; Gynecologic oncology
  • Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer. Albuquerque, K. V.; Singla, R.; Potkul, R. K.; Smith, D. M.; Creech, S.; Lo, S.; Emami, B.; Gynecologic oncology
  • Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention. Wakabayashi, M. T.; Da Silva, D. M.; Potkul, R. K.; Kast, W. M.; Intervirology
  • A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacy. Small, L. A.; Da Silva, D. M.; de Visser, K. E.; Velders, M. P.; Fisher, S. G.; Potkul, R. K.; Kast, W. M.; Clinical cancer research : an official journal of the American Association for Cancer Research
  • Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes. Contreras, D. N.; Krammer, P. H.; Potkul, R. K.; Bu, P.; Rossi, J. L.; Kaufmann, A. M.; Gissmann, L.; Qiao, L.; Journal of immunotherapy (Hagerstown, Md. : 1997)
  • Sonographic assessment of an inaccessible chemotherapy infusion port. Kalbhen, C. L.; Salomon, C. G.; Contreras, D. N.; Smith, D. M.; Potkul, R. K.; AJR. American journal of roentgenology
  • PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impaired. Nieland, J. D.; Loviscek, K.; Kono, K.; Albain, K. S.; McCall, A. R.; Potkul, R. K.; Fisher, S. G.; Velders, M. P.; Petersson, M.; Kiessling, R.; Kast, W. M.; Journal of immunotherapy (Hagerstown, Md. : 1997)
  • A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix. Irvin, W. P.; Price, F. V.; Bailey, H.; Gelder, M.; Rosenbluth, R.; Durivage, H. J.; Potkul, R. K.; Cancer
  • Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic mice. Michelin, D.; Gissmann, L.; Street, D.; Potkul, R. K.; Fisher, S.; Kaufmann, A. M.; Qiao, L.; Schreckenberger, C.; Gynecologic oncology
  • Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells. Street, D.; Kaufmann, A. M.; Vaughan, A.; Fisher, S. G.; Hunter, M.; Schreckenberger, C.; Potkul, R. K.; Gissmann, L.; Qiao, L.; Gynecologic oncology
  • High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. Stiff, P. J.; Bayer, R.; Kerger, C.; Potkul, R. K.; Malhotra, D.; Peace, D. J.; Smith, D.; Fisher, S. G.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Reply. Delgado, G.; Potkul, R. K.; Gynecologic oncology
  • Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Erlich, E.; McCall, A. R.; Potkul, R. K.; Walter, S.; Vaughan, A.; Gynecologic oncology
  • The variation of inguinal lymph node depth in adult women and its importance in planning elective irradiation for vulvar cancer. McCall, A. R.; Olson, M. C.; Potkul, R. K.; Cancer
  • Retroperitoneal radical hysterectomy. Delgado, G.; Potkul, R. K.; Dolan, J. R.; Gynecologic oncology
  • Vulvar reconstruction using a mons pubis pedicle flap. Potkul, R. K.; Barnes, W. A.; Barter, J. F.; Delgado, G.; Spear, S. L.; Gynecologic oncology